HIV-1 genotypic profiling ensures effective response to third-line antiretroviral therapy in Cameroon

In order to limit the emergence of human immunodeficiency virus (HIV) drug resistance in a context of limited antiretroviral options, we sought to evaluate the efficacy of third-line (3L) regimens considering HIV genotypic resistance profile at initiation of 3L in Cameroon. A cohort-study was conduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Mbouyap, Pretty Rosereine, Fokam, Joseph, Ngoufack Jagni Semengue, Ezechiel, Mossiang, Leonella, Takou, Désiré, Ambe Chenwi, Collins, Nka, Alex Durand, Dambaya, Beatrice, Teto, Georges, Angong Beloumou, Grâce, Djupsa Ndjeyep, Sandrine Claire, Ka’e, Aude Christelle, Kouanfack, Charles, Ndjolo, Alexis, Mbopi Keou, François–Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4850
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238024/
https://www.ncbi.nlm.nih.gov/pubmed/37266631
http://dx.doi.org/10.1097/MD.0000000000033897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238024/
https://www.ncbi.nlm.nih.gov/pubmed/37266631
http://dx.doi.org/10.1097/MD.0000000000033897

Ejemplares similares